CERT1

protein-coding

ceramide transporter 1, the group of StAR related lipid transfer domain containing|Pleckstrin homology domain containing

Gene summary

This gene encodes a kinase that specifically phosphorylates the N-terminal region of the non-collagenous domain of the alpha 3 chain of type IV collagen, known as the Goodpasture antigen. Goodpasture disease is the result of an autoimmune response directed at this antigen. One isoform of this protein is also involved in ceramide intracellular transport. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Previous symbols:
  • COL4A3BP

MANE transcript

NM_001379029.1

Inheritance

AD

ClinVar variants

P:13U:141B:55

Top phenotype

Neurodevelopmental disorder with hypotonia, speech delay, and dysmorphic facies

gnomAD constraint

pLI —, LoF o/e 0.21

Max pathogenic AF

—

Genomic locus

chr5:75,356,345-75,512,138

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~155.8 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

intellectual disability, autosomal dominant 34STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014599

Submitter: Labcorp Genetics (formerly Invitae)

intellectual disability, autosomal dominant 34DEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0014599

Submitter: G2P

Clinical Genomic Database (CGD)

Neurodevelopmental disorder with hypotonia, speech delay, and dysmorphic faciesAD

Manifestation: Craniofacial; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 25533962Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CERT1 variants in ClinVar

6 Conditions Cataloged
not providedTotal: 108
Inborn genetic diseasesTotal: 62
not specifiedTotal: 59
Intellectual disability, autosomal dominant 34Total: 27
CERT1-related disorderTotal: 13
COL4A3BP-related disorderTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001379029.1. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
36
clinvar
39
missense
2
clinvar
11
clinvar
128
clinvar
19
clinvar
160
nonsense
0
start loss
0
frameshift
4
clinvar
4
splice donor/acceptor (+/-2bp)
6
clinvar
6
Total211141550209

Highest pathogenic variant AF is 6.9288643e-7

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 42 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001379029.1RefSeqNP_001365958.117MANE Select
ENST00000643780.2EnsemblENSP00000495760.117MANE Select
NM_001130105.1RefSeqNP_001123577.118Standard
NM_001379002.1RefSeqNP_001365931.117Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
col4a3bpaDanio rerio

Structure: head

Quality: decreased size

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Sphingolipid Metabolism
  • Metabolism of lipids
  • Metabolism
  • Glycosphingolipid metabolism
  • Sphingolipid de novo biosynthesis

Biological Process

  • cell morphogenesis
  • in utero embryonic development
  • heart morphogenesis
  • ceramide metabolic process
  • muscle contraction

Molecular Function

  • protein binding
  • lipid binding
  • kinase activity
  • phosphatidylinositol-4-phosphate binding
  • ceramide binding

Cellular Component

  • nucleoplasm
  • mitochondrion
  • endoplasmic reticulum membrane
  • Golgi apparatus
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000380494
Coding exons
18
Length
143653
Individuals with no LoFs
125736
Homozygous LoFs
0
Heterozygous LoFs
10
Defined
125746
p
0.0000398
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.362724060.6700.00002044899
Missense (PolyPhen)52132.930.391191620
Synonymous-1.791751471.190.000007331458
Loss of Function4.81943.10.2090.00000229496

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000880.000087rare
Ashkenazi Jewish0.0000990.000099rare
East Asian00.0absent
Finnish0.0000510.000046rare
European (Non-Finnish)0.0000460.000044rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Shelters ceramides and diacylglycerol lipids inside its START domain and mediates the intracellular trafficking of ceramides and diacylglycerol lipids in a non-vesicular manner. {ECO:0000269|PubMed:14685229, ECO:0000269|PubMed:17591919, ECO:0000269|PubMed:18184806, ECO:0000269|PubMed:20036255}.;
Disease
DISEASE: Mental retardation, autosomal dominant 34 (MRD34) [MIM:616351]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:25356899, ECO:0000269|PubMed:25533962}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.0962

Intolerance Scores

LoFtool
0.197
RVIS EVS
-0.6
RVIS percentile EVS
17.75

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
K
Indispensability pred.
E
Indispensability score
0.879

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.